The European Medicines Agency (EMA) has started a safety review of the antidepressant Deanxit, authorized in Spain since 1972, due to reports of serious neurological effects in patients, such as tremors and memory problems. #Deanxit #saludmental #efectosadversos (translated)
www.abc.es
Europa pone bajo revisión un antidepresivo autorizado en España desde 1972 por efectos neurológicos graves
